review Open AccessTop 1% cited
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
Leukemia · 2008 · Vol. 23(2) · pp. 215–224
Angela Dispenzieri✉(WinnMed)Robert A. Kyle(Mayo Clinic in Arizona)Giampaolo MerliniJesús F. San Miguel(Centro de Investigación del Cáncer)Heinz Ludwig(Wilhelminen Hospital)Roman HájekAntonio Palumbo(University of Turin)Sundar Jagannath(Saint Vincent Health System)Joan Bladé(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer)Sagar Lonial(Emory University)Meletios Α. Dimopoulos(Alexandra Hospital)Raymond L. Comenzo(Memorial Sloan Kettering Cancer Center)Hermann Einsele(University of Würzburg)Bart BarlogieKenneth C. AndersonMorie A. Gertz(Mayo Clinic in Arizona)Jean‐Luc HarousseauMichel Attal(Hôpital Purpan)Patrizia Tosi(University of Bologna)Pieter Sonneveld(Rotterdam University of Applied Sciences)Mario Boccadoro(University of Turin)Gareth J. MorganPaul G. RichardsonOrhan Sezer(Berlin University of the Arts)María‐Victoria Mateos(Centro de Investigación del Cáncer)Michèle Cavo(University of Bologna)D. Joshua(Royal Prince Alfred Hospital)Ingemar Turesson(Malmö University)W. Chen(Beijing Chaoyang Emergency Medical Center)Kazuyuki Shimizu(Higashi Osaka City General Hospital)R Powles(Parkside Hospital)S. Vincent Rajkumar(Mayo Clinic in Arizona)Brian G.M. Durie(Cedars-Sinai Medical Center)on behalf of the International Myeloma Working Group
Amyloidosis: Diagnosis, Treatment, OutcomesMultiple Myeloma Research and TreatmentsMyeloproliferative Neoplasms: Diagnosis and TreatmentMultiple myelomaImmunoglobulin light chainImmunofixationContext (archaeology)Bone marrowMedicineAntibodyAL amyloidosisUrineMyeloma protein
MeSH terms
AmyloidosisHumansImmunoglobulin kappa-ChainsImmunoglobulin lambda-ChainsImmunoglobulin Light ChainsMethodsMultiple MyelomaPrognosisDisease ManagementNeoplasms, Plasma Cell
Citations
802
FWCI
18.34
field-weighted impact
References
47
Percentile
100%
vs. same field & year
Citations per year
Cited by
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2017 · 866 citations
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
The Lancet Oncology · 2016 · 2,897 citations
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
The Lancet Oncology · 2014 · 4,761 citations
References
Highly Sensitive, Automated Immunoassay for Immunoglobulin Free Light Chains in Serum and Urine
Clinical Chemistry · 2001 · 639 citations
Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy
British Journal of Haematology · 2003 · 430 citations
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
British Journal of Haematology · 1998 · 1,525 citations
International uniform response criteria for multiple myeloma
Leukemia · 2006 · 2,623 citations
International Staging System for Multiple Myeloma
Journal of Clinical Oncology · 2005 · 2,894 citations
Serum Reference Intervals and Diagnostic Ranges for Free κ and Free λ Immunoglobulin Light Chains: Relative Sensitivity for Detection of Monoclonal Light Chains
Clinical Chemistry · 2002 · 609 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
